Profil
Salim Yazji is the founder of Elpida Therapeutics, Ajuta Therapeutics, Inc., and Versatope Therapeutics, Inc. He is currently the Director at Versatope Therapeutics, Inc. Dr. Yazji's former positions include Vice President-Global Therapeutics at Baxalta, Inc., Chief Medical Officer & Executive Vice President at Calimmune, Inc., and Chief Medical Officer at PMV Pharmaceuticals, Inc. He also served as the Chief Medical Officer at Oncternal Therapeutics, Inc. from 2021 to 2024.
Dr. Yazji obtained a doctorate degree from Pavlov First Saint Petersburg State Medical University.
Postes actifs de Salim Yazji
| Sociétés | Poste | Début |
|---|---|---|
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Operates as immuno-therapeutic company | Directeur/Membre du Conseil | 01/04/2019 |
Elpida Therapeutics | Fondateur | - |
Anciens postes connus de Salim Yazji
| Sociétés | Poste | Fin |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2024 |
| BAXALTA INC | Corporate Officer/Principal | - |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Directeur Technique/Scientifique/R&D | - |
| PMV PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Ajuta Therapeutics, Inc. | Directeur Général | - |
Formation de Salim Yazji
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Pavlov First Saint Petersburg State Medical University
Pavlov First Saint Petersburg State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Operates as immuno-therapeutic company | Health Technology |
Ajuta Therapeutics, Inc. | |
Elpida Therapeutics |
















